THE Philippines got another boost in its vaccination efforts against the coronavirus disease 2019 (Covdi-19) with the arrival of 2.28 million doses of Pfizer-BioNTech Tozinameran from the global Covax facility on Thursday night. The vaccines will be used in the A1 to A3 priority groups, which consist of frontline healthcare workers, senior citizens, and persons with co-morbidities. According to Health Secretary Francisco Duque 3rd, it is.
Following the expansion of the emergency use authorization (EUA) of Pfizer’s COVID-19 vaccine to cover individuals aged 12 and above, Health Secretary Francisco Duque III said the Philippine Pediatrics Society (PPS) and the Pediatric Infectious Disease Society of the Philippines (PIDSP) have vowed to study the inoculation of children younger than 12 against COVID-19.
There is still no strong evidence that the anti-parasitic drug ivermectin could be used as a possible treatment against COVID-19, Health Secretary Francisco Duque III said on Monday.